Ajay Major

Ajay Major: Liso-cel in DLBCL with secondary CNS diagnosis by Jennifer Crombie

Ajay Major, Assistant Professor of Medicine at the University of Colorado School of Medicine, shared a post on X about a new abstract by Jennifer Crombie, Hematologist/oncologist at Dana Farber’s Cancer Center:

“Liso-cel in DLBCL with secondary CNS diagnosis.

  • 36 patients (CIBMTR), 83% parenchymal, 97% active diagnosis at CAR
  • ORR 64%, CR 53%, 1-yr DOR 55%
  • 1-yr PFS 36%, OS 39%, almost all deaths from POD
  • G3 CRS 8%, ICANS 22% (no G4-5)

Still bad outcomes in this setting.”

“Real-World (RW) Outcomes of Lisocabtagene Maraleucel (liso-cel) in Patients (pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL) and Secondary Central Nervous System (sCNS) Involvement from the Center for International Blood and Marrow Transplant Research (CIBMTR) Registry”

Authors: Sairah Ahmed, Avyakta Kallam, Matthew Frigault, Marcelo Pasquini, Jennifer Crombie et al.

Ajay Major: Liso-cel in DLBCL with secondary CNS diagnosis by Jennifer Crombie

More posts featuring Ajay Major.

Ajay Major is an Assistant Professor of Medicine at the University of Colorado School of Medicine, specializing in lymphoma and CLL/SLL. He is the Founder and President of Pager Publications, as well as the Founder and Editor-in-Chief of in-House. Additionally, he serves as a Reviewer for the Bellevue Literary Review.

Ajay Major ASH24 Avyakta Kallam cancer CIBMTR Diffuse Large B-Cell Lymphoma DLBCL Jennifer Crombie Liso-cel Marcelo Pasquini Matthew Frigault OncoDaily Oncology Sairah Ahmed